Bionano Genomics (BNGO) Other Accumulated Expenses (2024 - 2026)

Bionano Genomics has reported Other Accumulated Expenses for 3 years, with the latest figure at $458000.0 in Q1 2026.

• Quarterly Other Accumulated Expenses changed N/A year-over-year to $458000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $458000.0 (changed N/A YoY) and the FY2025 annual result came in at $502000.0, up 3037.5% from the prior year.
• Other Accumulated Expenses fell to $458000.0 in Q1 2026 per BNGO's latest filing, from $502000.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $502000.0 in Q4 2025 and troughed at $16000.0 in Q4 2024.
• A 3-year average of $325333.3 and a median of $458000.0 in 2026 frame the typical range for Other Accumulated Expenses.
• The widest YoY moves for Other Accumulated Expenses: up 3037.5% in 2025, down 3037.5% in 2025.
• Over 3 years, Other Accumulated Expenses stood at $16000.0 in 2024, then jumped by 3037.5% to $502000.0 in 2025, then slipped by 8.76% to $458000.0 in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $458000.0, $502000.0, and $16000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.